Giant Group (02367) received an additional 2.066 million shares of the company's stock from its controlling shareholder.

Zhixin Finance APP News, Juzi Biotech (02367) announced that the Board of Directors received a notification from the company's controlling shareholder, Juzi Holding Co., Ltd. (Juzi Holding), expressing strong confidence in the company's future development and aiming to promote the company's continued, stable, and healthy growth, as well as protect the interests of the general public investors. Since the announcement of the increased shareholding plan on June 9, 2025, as of the date of this announcement, Juzi Holding has collectively purchased 2.066 million shares of the company's stock on the market, with a total increase in holdings of approximately HKD 105.6 million (excluding commissions and other expenses). Following this recent increase, as of the date of this announcement, Juzi Holding holds a total of approximately 583 million shares of the company, accounting for 54.45% of the total issued shares of the company. Juzi Holding may further increase its stake in the company based on market conditions and applicable regulatory requirements.